Episode
EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
- Podcast
- Lung Cancer Update
- Published
- Jun 20, 2025
- Duration seconds
- 7071
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/lung-cancer-update-827388/episodes/egfr-mutation-positive-non-small-cell-lung-cancer-proceedings-from-a-session-held-during-the-2025-asco-annual-meeting/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/lung-cancer-update-827388/egfr-mutation-positive-non-small-cell-lung-cancer-proceedings-from-a-session-held-during-the-2025-asco-annual-meeting.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi Jänne, Dr Suresh Ramalingam, Dr Joshua Sabari and moderator Dr Helena Yu present data informing treatment decision-making for EGFR-mutated NSCLC at the 2025 ASCO annual meeting. CME information and select publications here .